GNRH1 and coronary artery disorder: Although there are no definite data on the role of anthracyclines in increasing risk for ischemic heart disease, and especially on their synergistic effects when used combination with GnRH analogues, the cardiotoxic effects of this drug class are renowned and well-documented.